Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DANAPAROID' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 50 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lindhoff-Last, E; Betz, T; Bauersachs, R
      Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    2. Miyake, Y; Yokota, K; Fujishima, Y; Sukamoto, T
      The effects of danaparoid, dalteparin and heparin on tissue factor-inducedexperimental disseminated intravascular coagulation and bleeding time in the rat

      BLOOD COAGULATION & FIBRINOLYSIS
    3. Harrison, SJ; Rafferty, I; McColl, MD
      Management of heparin allergy during pregnancy with danaparoid

      BLOOD COAGULATION & FIBRINOLYSIS
    4. Zohrer, B; Zenz, W; Rettenbacher, A; Covi, P; Kurnik, K; Kroll, H; Grubbauer, HM; Muntean, W
      Danaparoid sodium (Orgaran((R))) in four children with heparin-induced thrombocytopenia type II

      ACTA PAEDIATRICA
    5. Salmi, L; Leroy-Matheron, C; LeBesnerais, P; Rosanval, O; Duvaldestin, P; Gouault-Heilmann, M
      Coronary bypass with sodic danaparold for value replacement during thrombocytopenia due to type II heparin.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    6. Godet, G; Bertrand, M; Van de Steen, E; Boccara, G; Koskas, F
      Danaparoide and heparin-induced thrombocytopaenia.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    7. Chong, BH; Gallus, AS; Cade, JF; Magnani, H; Manoharan, A; Oldmeadow, M; Arthur, C; Rickard, K; Gallo, J; Lloyd, J; Seshadri, P; Chesterman, CN
      Prospective randomised open-label comparison of danaparoid with dextran 70in the treatment of heparin-induced thrombocytopaenia with thrombosis - A clinical outcome study

      THROMBOSIS AND HAEMOSTASIS
    8. Schick, BP; Gradowski, JF; San Antonio, JD; Martinez, J
      Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans

      THROMBOSIS AND HAEMOSTASIS
    9. Fedullo, PF; Auger, WR; Channick, RN; Kerr, KM; Rubin, LJ
      Chronic thromboembolic pulmonary hypertension

      CLINICS IN CHEST MEDICINE
    10. Keng, TB; Chong, BH
      Heparin-induced thrombocytopenia and thrombosis syndrome: in vivo cross-reactivity with danaparoid and successful treatment with r-Hirudin

      BRITISH JOURNAL OF HAEMATOLOGY
    11. Whelen, S; Carr, ME
      Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure - A case report

      ANGIOLOGY
    12. von Lupke, U; Marx, A; Tessmann, R; Lindhoff-Last, E
      Danaparoid(Orgaran)as anticoagulant for autotransfusion with Cell Saver 5 (Haemonetics)

      ANAESTHESIST
    13. Macchi, L; Sarfati, R; Guicheteau, H; Chamlian, V; Pourrat, O; Gruel, Y; Magnin, G; Brizard, A; Boinot, C
      Thromboembolic prophylaxis with danaparoid (Orgaran (R)) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's disease

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    14. Olin, DA; Urdaneta, F; Lobato, EB
      Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    15. Morewood, GH
      Uncomplicated heparinization for cardiopulmonary bypass in a patient with antiheparin antibodies

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    16. Neuhaus, TJ; Goetschel, P; Schmugge, M; Leumann, E
      Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid

      PEDIATRIC NEPHROLOGY
    17. Lubenow, N; Greinacher, A
      Management of patients with heparin-induced thrombocytopenia: Focus on recombinant hirudin

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    18. Elalamy, I; Lecrubier, C; Horellou, MH; Conard, J; Samama, MM
      Heparin-induced thrombocytopenia: laboratory diagnosis and management

      ANNALS OF MEDICINE
    19. de Saint-Blanquat, L; Simon, L; Toubas, MF; Hamza, J
      Treatment with danaparoid during pregnancy for a woman with a cutaneous allergy to low-weight molecular heparin.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    20. Frederiksen, JW
      Cardiopulmonary bypass in humans: Bypassing unfractionated heparin

      ANNALS OF THORACIC SURGERY
    21. Zmuda, K; Neofotistos, D; Ts'ao, C
      Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation

      AJCP. American journal of clinical pathology
    22. Mammen, EF
      Low molecular weight heparins and heparin-induced thrombocytopenia

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    23. Pini, M
      Future prospects of prophylaxis for deep vein thrombosis

      BLOOD COAGULATION & FIBRINOLYSIS
    24. Elalamy, I; Page, Y; Viallon, A; Tardy, B; Conard, J; Helft, G
      The diagnosis and development of heparin-induced thrombocytopenia. Clinical and biological aspects.

      REVUE DES MALADIES RESPIRATOIRES
    25. Danne, T; Kordonouri, O; Casani, A; Chiarelli, F
      Diabetic retinopathy in childhood and adolescents

      DIABETES NUTRITION & METABOLISM
    26. Bergqvist, D; Breddin, K; ten Cate, JW; Davidson, JF; Haas, S; Leyvraz, PF; Samama, M; Horellou, MH; Verstraete, M
      Thromboprophylaxis in hip fracture surgery: A pilot study comparing danaparoid, enoxaparin and dalteparin

      HAEMOSTASIS
    27. van der Woude, FJ
      Heparins in diabetic microangiopathy: Rationale and preliminary clinical results

      HAEMOSTASIS
    28. Harenberg, J; Huhle, G; Wang, L; Hoffmann, U; Bayerl, C; Kerowgan, M
      Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG

      ALLERGY
    29. Nguyen, P; De Maistre, E; Cornillet-Lefebvre, P; Regnault, V; Lecompte, T
      Heparin-induced thrombocytopenia in France, 1980-1998

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    30. Warkentin, TE
      Heparin-induced thrombocytopenia: A ten-year retrospective

      ANNUAL REVIEW OF MEDICINE
    31. Kleinschmidt, S; Seyfert, UT
      Heparin-induced thrombocytopenia (HIT). Importance for anesthesia and intensive care medicine

      ANAESTHESIST
    32. CHRISTIANSEN S; GEIGER A; SPLITTGERBER FH; REIDEMEISTER JC
      CORONARY-ARTERY BYPASS-GRAFTING IN A PATIENT WITH TYPE-II HEPARIN-ASSOCIATED THROMBOPENIA

      Cardiovascular surgery
    33. Roe, SD; Cassidy, MJD; Haynes, AP; Byrne, JL
      Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    34. SAUER M; GRUHN B; FUCHS D; ALTERMANN W; ZINTL F
      HEPARIN-ASSOCIATED THROMBOCYTOPENIA (HAT- II) IN A PATIENT UNDERGOINGHIGH-DOSE CHEMOTHERAPY WITH CONSECUTIVE STEM CELL-RESCUE

      Klinische Padiatrie
    35. Lecompte, T; de Maistre, E; Wahl, D
      Heparin-induced thrombocytopenia: new treatments

      REVUE DE MEDECINE INTERNE
    36. FUJISHIMA Y; YOKOTA K; SUKAMOTO T
      THE EFFECT OF DANAPAROID SODIUM (DANAPAROID) ON ENDOTOXIN-INDUCED EXPERIMENTAL DISSEMINATED INTRAVASCULAR COAGULATION (DIC) IN RATS

      Thrombosis research
    37. ISHIDA M; NAKADA Y; HORIUCHI M; SAKAMOTO F
      PHARMACOKINETICS OF DANAPAROID SODIUM, DALTEPARIN SODIUM AND HEPARIN DETERMINED BY INHIBITORY EFFECT ON THE ACTIVATED COAGULATION-FACTOR-X ACTIVITY AFTER SINGLE INTRAVENOUS ADMINISTRATION IN RABBITS

      Arzneimittel-Forschung
    38. SKOUTAKIS VA
      DANAPAROID IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS

      The Annals of pharmacotherapy
    39. GROCOTT HP; ROOT J; BERKOWITZ SD; DEBRUIJN N; LANDOLFO K
      COAGULATION COMPLICATING CARDIOPULMONARY BYPASS IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA RECEIVING THE HEPARINOID, DANAPAROID SODIUM

      Journal of cardiothoracic and vascular anesthesia
    40. VANBARLINGEN HHJJ; VANBEEK A; ERKELENS DW; DEBRUIN TWA
      DANAPAROID - AN ANTITHROMBOTIC AGENT WITHOUT MAJOR IMPACT ON TRIGLYCERIDE HYDROLYSIS CAPACITY IN HUMANS

      Journal of internal medicine
    41. THOLL U; GREINACHER A; OVERDICK K; ANLAUF M
      LIFE-THREATENING ANAPHYLACTIC REACTION FOLLOWING PARATHYROIDECTOMY INA DIALYSIS PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA

      Nephrology, dialysis, transplantation
    42. WESTPHAL K; MARTENS S; STROUHAL U; MATHEIS G; LINDHOFFLAST E; WIMMERGREINECKER G; LISCHKE V
      HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II - PERIOPERATIVE MANAGEMENT USING DANAPAROID IN A CORONARY-ARTERY BYPASS PATIENT WITH RENAL-FAILURE

      The thoracic and cardiovascular surgeon
    43. GINDRE J; DEMAISTRE E; PERRIN A; LECOMPTE T; HOFFMAN MA
      USE OF DANAPAROID (ORGARAN(R)) - ABOUT 13 MONOCENTRIC CASES UNDER THEREGULATION OF TEMPORARY AUTHORIZATION FOR PRESCRIBING MEDICINES (ATU)

      Therapie
    44. POUPLARD C; AMIRAL J; BORG JY; VISSAC AM; DELAHOUSSE B; GRUEL Y
      DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED IN HEPARIN-INDUCED THROMBOCYTOPENIA AND CONSEQUENCES ON CROSS-REACTIVITY WITH DANAPAROID SODIUM

      British Journal of Haematology
    45. GILLIS S; MERIN G; ZAHGER D; DEEB M; DRENGER B; HYAM E; ELDOR A
      DANAPAROID FOR CARDIOPULMONARY BYPASS IN PATIENTS WITH PREVIOUS HEPARIN-INDUCED THROMBOCYTOPENIA

      British Journal of Haematology
    46. SCHEFFLER E; AULMANN M; REMPPIS A; ZIEGLER R; MARTIN E; FLEISCHER F; NAWROTH P
      SUCCESSFUL USE OF THE HEPARINOID DANAPAROID-SODIUM DURING AORTIC-VALVE PROTHESIS REPLACEMENT IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II

      Zeitschrift fur Kardiologie
    47. BOON DMS; KAPPERSKLUNNE MC; MICHIELS JJ; STIBBE J; VANVLIET HHDM
      HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS - A POTENTIAL FATAL COMPLICATION IN A ROUTINE TREATMENT

      Netherlands journal of medicine
    48. RAMAKRISHNA R; MANOHARAN A; KWAN YL; KYLE PW
      HEPARIN-INDUCED THROMBOCYTOPENIA - CROSS-REACTIVITY BETWEEN STANDARD HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN, DALTEPARIN (FRAGMIN) AND HEPARINOID, DANAPAROID (ORGARAN)

      British Journal of Haematology
    49. DEVALK HW; BANGA JD; WESTER JWJ; BROUWER CB; VANHESSEN MWJ; MEUWISSEN OJAT; HART HC; SIXMA JJ; NIEUWENHUIS HK
      COMPARING SUBCUTANEOUS DANAPAROID WITH INTRAVENOUS UNFRACTIONATED HEPARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM - A RANDOMIZED CONTROLLED TRIAL

      Annals of internal medicine
    50. SIVAKUMARAN M; GHOSH K; MUNKS R; GELSTHORPE K; TAN L; WOOD JK
      DELAYED CUTANEOUS REACTION TO UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN AND DANAPAROID

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 05:52:03